Lilly plots GLP-1 pill production boost in China, $500M pledge to South Koreanews2026-03-11T15:15:38+00:00March 11th, 2026|Endpoints News|
UCB says Bimzelx tops Skyrizi in trial; Xenon, Dianthus set share salesnews2026-03-11T14:52:55+00:00March 11th, 2026|Endpoints News|
Eli Lilly CEO David Ricks seeks ‘exit velocity’ for pharma’s futurenews2026-03-11T14:37:56+00:00March 11th, 2026|Endpoints News|
